Publications by Dr Duddy Duddy - ePrints

Browsing publications by Dr Duddy Duddy.

Newcastle Authors	Title	Year
Dr Duddy Duddy	Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UK	2024
Dr Kirstie Anderson Dr Naomi Warren Dr Duddy Duddy Dr James Miller	Delivering an advice and guidance service in neurology	2022
Dr Duddy Duddy	Self-diagnosed COVID-19 in people with multiple sclerosis: A community-based cohort of the UK MS Register	2021
Hannah Lowes Dr Angela Pyle Dr Duddy Duddy Professor Gavin Hudson	Cell-free mitochondrial DNA in progressive multiple sclerosis	2019
Dr Duddy Duddy	A severe, relapsing case of myelin oligodendrocyte glycoprotein IgG-associated CNS inflammation	2018
Dr Duddy Duddy	Seizures and encephalitis in myelin oligodendrocyte glycoprotein IgG disease vs aquaporin 4 IgG disease	2018
Dr Duddy Duddy	The state of multiple sclerosis: current insight into the patient/health care provider relationship, treatment challenges, and satisfaction	2017
James Chapman Dr David Lewis-Smith Dr Joseph Guadagno Dr Duddy Duddy	The Newcastle Experience of Anti-Mog Associated Disease	2016
Dr Duddy Duddy	The UK risk sharing scheme: Final 10 years analysis	2016
Dr Duddy Duddy	The UK risk-sharing scheme for interferon-beta and glatiramer acetate in multiple sclerosis. Outcome of the year-6 analysis	2016
Dr Duddy Duddy	Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator	2015
Dr Joseph Guadagno Dr Duddy Duddy Emerita Professor Julia Newton	Exploring the association between fatigue and autonomic dysfunction in multiple sclerosis	2015
Dr Matthew Alexander Dr Duddy Duddy Dacia Jones Gill O'Neill	The state of MS: treatment goals and challenges	2015
Dr Joseph Guadagno Dr Duddy Duddy	Fingolimod in Newcastle: The First 100 Patients' Experience	2014
Dr Duddy Duddy	The conversation is changing: be part of it	2014
Dr Duddy Duddy	The state of MS: current insight into patient-neurologist relationships, barriers to communication and treatment satisfaction	2014
Dr Duddy Duddy	The UK MS Risk-Sharing Scheme: Results for Years 4 and 6	2014
Dr Duddy Duddy Dr Martin Lee	The UK patient experience of relapse in Multiple Sclerosis treated with first disease modifying therapies	2014
Dr Duddy Duddy	UK multiple sclerosis risk-sharing scheme: a new natural history dataset and an improved Markov model	2014
Dr Duddy Duddy	A Decade of Data for the UK Multiple Sclerosis Risk–Sharing Scheme	2013
Dr Duddy Duddy	A UK-based study of the impact of relapse on clinical decision making early in the course of first-line disease modifying therapy	2013
Dr Duddy Duddy	Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis	2013
Dr Duddy Duddy	Improving the Model for the UK MS Disease Modifying Treatment Risk Sharing Scheme Analysis: A New Natural History Dataset	2013
Dr Duddy Duddy	The international multiple sclerosis clinic - A virtual tour of best practice multiple sclerosis nursing	2013
Professor Mark Baker Dr Karen Fisher Dr Duddy Duddy Professor Stuart Baker	Slow Orthostatic Tremor in Multiple Sclerosis	2009
Dr Duddy Duddy Professor Mark Baker	Stiff person syndrome	2009
Dr Stephan Jaiser Dr Duddy Duddy	Copper deficiency masquerading as subacute combined degeneration of the cord and myelodysplastic syndrome	2007
Dr Duddy Duddy Professor Mark Baker	Harlequin's darker side	2007
Dr Duddy Duddy	Cerebroventricular infusion of pentosan polysulphate in human variant Creutzfeldt-Jakob disease	2005